Adverse events · adults with metastatic extradural spinal cord compression (fit for surgery, paraplegic less than 48 hours, and without multiple discrete…
1 finding from 1 review
Serious adverse events · adults with fibromyalgia enrolled in EERW studies
1 finding from 1 review
Serious adverse events · adults with fibromyalgia
1 finding from 1 review
Adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Withdrawals due to adverse events · adults with fibromyalgia
1 finding from 1 review
Serious adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Serious adverse events · patients with fibromyalgia
Pregabalin showed no clear difference in serious adverse events compared with placebo at end of treatment (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with fibromyalgia
Pregabalin leads to higher withdrawal due to adverse events compared with placebo at end of treatment (high certainty).
1 finding from 1 review
Withdrawals due to adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Adverse events · adults with metastatic extradural spinal cord compression (single lesion, no prior radiotherapy, fit for surgery)
1 finding from 1 review
Serious adverse events · adults with metastatic extradural spinal cord compression (without peptic ulceration or infection; mixed prognosis)
High‐dose corticosteroids probably leads to higher serious adverse events compared with moderate‐dose or no corticosteroids (moderate certainty).
1 finding from 1 review
Adverse events · preterm born neonates
1 finding from 1 review
Adverse events · preterm born neonates
1 finding from 1 review
Adverse events · preterm born neonates
1 finding from 1 review
Number withdrawn due to adverse events · patients for whom migraine preventive interventions are indicated
It is very uncertain whether SSRIs or SNRIs changes withdrawn (due to adverse events) compared with placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with tension‐type headache
SSRIs or SNRIs showed no clear difference in withdrawals due to adverse events compared with other antidepressants (low certainty).
1 finding from 1 review
Participants who withdraw because of an adverse event or any other reason · patients for whom migraine preventive interventions are indicated
SSRIs or SNRIs showed no clear difference in withdrawn (for any reasons and due to adverse events) compared with amitriptyline (low certainty).
1 finding from 1 review
Adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Adverse events · children (4 to 18 years) with functional abdominal pain disorders
1 finding from 1 review
Adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review